Our client, the Head of Development of a global pharmaceutical company in post merger situation, sought to build a world class development capability . Differences in legacy company cultures had to be overcome.
A diagnostic report had been created by another provider, and Kinapse were subsequently selected to lead the change phases.
Using our change management methodology and the existing diagnostic to execute design, implementation and benefits realization phases, the project had complementary work streams to:
Successfully able to establish new ways of working owned by the whole merged development organization, not linked to one Legacy Company.
Increased reliability of clinical development program time, cost and resource management.
Major change program delivered with minimal disruption to core development business, allowing significant clinical program successes to be reported in parallel to the far-reaching process and interface change.